Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01483274
Title Decitabine and Vaccine Therapy for Patients With Relapsed AML Following Allogeneic Stem Cell Transplantation
Acronym AML
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Louisville
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Louisville Louisville Kentucky 40202 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field